BWH Logo LABORATORY FOR NANOMEDICINE
Sengupta Laboratory
HST Logo
Page Banner Image of a Globe
Harvard University

   Indo-US Joint
   Center for
   Nanobio-
   technology


MIT
    Home     |     Team     |     Publications     |     News     |     Funding
SELECTED PUBLICATIONS

  • Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Reiberger T, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, Jain RK, Edelman E, Sengupta S. Physical nanoscale conduits-mediated communication between tumor cells and endothelium enables a metastatic hijack. Nature Communications (2015) To appear.

  • Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu GK, Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S, Sengupta S, Sundaram M, Majumder PK. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nature Communications (2015) 6:6169.

  • Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nature Communications (2015) 6:6139.

  • Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh M, Basu S, Kohandel M, Sengupta S. Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy. Cancer Res. (2014) 74(3):675-85.

  • Kulkarni AA, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A, Kotamraju VR, Basu S, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S. Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy. Cancer Res. (2013) 73(23):6987-97

  • Sengupta S, Kulkarni A. Design principles for clinical efficacy of cancer nanomedicine: a look into the basics. ACS Nano (2013) 7(4):2878-82.

  • Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc. Natl. Acad. Sci. USA (2012) 109:11294-9.

  • Sinha Roy R, Soni S, Harfouche R, Vasudevan PR, Holmes O, de Jonge H, Rowe A, Paraskar A, Hentschel DM, Chirgadze D, Blundell TL, Gherardi E, Mashelkar RA, Sengupta S. Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. Proc. Natl. Acad. Sci. USA (2010) 107(31):13608-13.

  • Paraskar AS, Soni S, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ, Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy. Proc. Natl. Acad. Sci. USA (2010) 107(28):12435-40.
    [Featured in Harvard Gazette and MIT News.]

  • Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S. Shape effect of carbon nanovectors on angiogenesis. ACS Nano (2010) 4(1):574-82.

  • Harfouche R, Hentschel D, Piecewicz SM, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S. Glycome and transcriptomal regulation of vasculogenesis. Circulation (2009) 120(19):1883-92.

  • Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S. Fullerenol-Cytotoxic Conjugates for Cancer Chemotherapy. ACS Nano (2009) 3(9):2505-14.

  • Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc. Natl. Acad. Sci. USA (2009) 106(19):7957-61.
    [Featured in HarvardScience, USNews, The Telegraph, etc.]

  • Sengupta S, Eavarone DA, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. Novel cancer therapy through temporal targeting of both tumor cells and neovasculature using a unique nanoscale delivery system. Nature (2005) 436:568-72.
    [Featured in Nature News and Views, Tech Review, MIT website Spot Light, BBC, MSNBC, FOX TV, The Telegraph, Boston Globe, etc.]

  • Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RNS, Sasisekharan R, Fan TP. Modulating angiogenesis - The yin and the yang in ginseng. Circulation (2004) 104:1219-1225.
    [Featured in Science Editor's Choice (10th Sep), Forbes (7th Sep), Washington Post (30th Aug), US Today, Petra (5th Sep, Greece), Folca (Brazil), Tech Review (Jan 05), U.S. Department of State release (31st Aug), NIGMS press release.]

  • Qi Y, Zhao G, Liu D, Shriver Z, Sundaram M, Sengupta S, Venkataraman G, Langer R, Sasisekharan R. Delivery of therapeutic levels of heparin and low molecular weight heparin through a pulmonary route. Proc. Natl. Acad. Sci. USA (2004) 101:9867-9872.

  • Sengupta S, Kiziltepe T, Sasisekharan R. A dual color fluorescence imaging-based system for the dissection of the antiangiogenic and chemotherapeutic properties of molecules. FASEB J. (2004) (doi:10.1096/fj.04-1934fje)

  • Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman TC, Tom BDM, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. (2004) 18:188-190.

  • Sengupta S, Sellers LA, Cindrova T, Skepper JN, Gherardi E, Sasisekheran R, Fan TP. Cyclooxygenase-2-selective non steroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res. (2003) 63:8351-8359.

  • Sengupta S, Sellers LA, Li R, Zhao G, Gherardi E, Sasisekharan R, Fan TP. Targeting of mitogen activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation (2003) 107:2955-2961.


   Brigham and Women's Hospital   |  Room 317, PRB, 65 Landsdowne Street, Cambridge, MA 02139   |  Tel: 617-768-8994

   © 2008 Sengupta Laboratory